SEARCH

SEARCH BY CITATION

In Ref.1, Figure 1 contained an error in which Finland was shown in yellow colour (availability of infliximab, 0–25%), where it should have been shown in blue colour (availability of infliximab, 76–100%). The corrected Figure 1 is printed below.

image

Figure 1.  Gastroenterologists’ perceptions of availability of infliximab in their own countries. As the information was not made available by the manufacturer or distributor of infliximab, gastroenterologists around the world were contacted and asked to estimate what proportion of their country’s population had access to infliximab to induce remission for active Crohn’s disease. African gastroenterologists provided data for more than one country.

Download figure to PowerPoint

References

  1. Top of page
  2. References